R A Sorabella1, L Guglielmetti1, A Kantor1, E Castillero1, H Takayama1, P C Schulze2, D Mancini2, Y Naka1, I George3. 1. Division of Cardiothoracic Surgery, New York Presbyterian Hospital, Columbia University College of Physicians and Surgeons, New York, New York, USA. 2. Division of Cardiology, New York Presbyterian Hospital, Columbia University College of Physicians and Surgeons, New York, New York, USA. 3. Division of Cardiothoracic Surgery, New York Presbyterian Hospital, Columbia University College of Physicians and Surgeons, New York, New York, USA. Electronic address: ig2006@cumc.columbia.edu.
Abstract
INTRODUCTION: To address the shortage of donor hearts for transplantation, there is significant interest in liberalizing donor acceptance criteria. Therefore, the aim of this study was to evaluate cardiac donor characteristics from the United Network for Organ Sharing (UNOS) database to determine their impact on posttransplantation recipient outcomes. METHODS: Adult (≥18 years) patients undergoing heart transplantation from July 1, 2004, to December 31, 2012, in the UNOS Standard Transplant Analysis and Research (STAR) database were reviewed. Patients were stratified by 1-year posttransplantation status; survivors (group S, n = 13,643) and patients who died or underwent cardiac retransplantation at 1-year follow-up (group NS/R = 1785). Thirty-three specific donor variables were collected for each recipient, and independent donor predictors of recipient death or retransplantation at 1 year were determined using multivariable logistic regression analysis. RESULTS: Overall 1-year survival for the entire cohort was 88.4%. Mean donor age was 31.5 ± 11.9 years, and 72% were male. On multivariable logistic regression analysis, donor age >40 years (odds ratio [OR] 1.44, 95% confidence interval [CI] 1.27 to 1.64), graft ischemic time >3 hours (OR 1.32, 1.16 to 1.51), and the use of cardioplegia (OR 1.17, 1.01 to 1.35) or Celsior (OR 1.21, 1.06 to 1.38) preservative solution were significant predictors of recipient death or retransplantation at 1 year posttransplantation. Male donor sex (OR 0.83, 0.74 to 0.93) and the use of antihypertensive agents (OR 0.88, 0.77 to 1.00) or insulin (OR 0.84, 0.76 to 0.94) were protective from adverse outcomes at 1 year. CONCLUSIONS: These data suggest that donors who are older, female, or have a long projected ischemic time pose greater risk to heart transplant recipients in the short term. Additionally, certain components of donor management protocols, including antihypertensive and insulin administration, may be protective to recipients.
INTRODUCTION: To address the shortage of donor hearts for transplantation, there is significant interest in liberalizing donor acceptance criteria. Therefore, the aim of this study was to evaluate cardiac donor characteristics from the United Network for Organ Sharing (UNOS) database to determine their impact on posttransplantation recipient outcomes. METHODS: Adult (≥18 years) patients undergoing heart transplantation from July 1, 2004, to December 31, 2012, in the UNOS Standard Transplant Analysis and Research (STAR) database were reviewed. Patients were stratified by 1-year posttransplantation status; survivors (group S, n = 13,643) and patients who died or underwent cardiac retransplantation at 1-year follow-up (group NS/R = 1785). Thirty-three specific donor variables were collected for each recipient, and independent donor predictors of recipient death or retransplantation at 1 year were determined using multivariable logistic regression analysis. RESULTS: Overall 1-year survival for the entire cohort was 88.4%. Mean donor age was 31.5 ± 11.9 years, and 72% were male. On multivariable logistic regression analysis, donor age >40 years (odds ratio [OR] 1.44, 95% confidence interval [CI] 1.27 to 1.64), graft ischemic time >3 hours (OR 1.32, 1.16 to 1.51), and the use of cardioplegia (OR 1.17, 1.01 to 1.35) or Celsior (OR 1.21, 1.06 to 1.38) preservative solution were significant predictors of recipient death or retransplantation at 1 year posttransplantation. Male donor sex (OR 0.83, 0.74 to 0.93) and the use of antihypertensive agents (OR 0.88, 0.77 to 1.00) or insulin (OR 0.84, 0.76 to 0.94) were protective from adverse outcomes at 1 year. CONCLUSIONS: These data suggest that donors who are older, female, or have a long projected ischemic time pose greater risk to heart transplant recipients in the short term. Additionally, certain components of donor management protocols, including antihypertensive and insulin administration, may be protective to recipients.
Authors: Andreas Brieke; Rajan Krishnamani; Michael J Rocha; Wenjun Li; Richard D Patten; Marvin A Konstam; Ayan R Patel; James E Udelson; David Denofrio Journal: J Heart Lung Transplant Date: 2008-10-26 Impact factor: 10.247
Authors: Leanne B Gasink; Emily A Blumberg; A Russell Localio; Shashank S Desai; Ajay K Israni; Ebbing Lautenbach Journal: JAMA Date: 2006-10-18 Impact factor: 56.272
Authors: K S Dujardin; R B McCully; E F Wijdicks; H D Tazelaar; J B Seward; C G McGregor; L J Olson Journal: J Heart Lung Transplant Date: 2001-03 Impact factor: 10.247
Authors: Veli K Topkara; Faisal H Cheema; Satish Kesavaramanujam; Michelle L Mercando; Catherine S Forster; Michael Argenziano; Barry C Esrig; Mehmet C Oz; Yoshifumi Naka Journal: J Card Surg Date: 2006 Mar-Apr Impact factor: 1.620
Authors: Mark J Russo; Ryan R Davies; Kimberly N Hong; Jonathan M Chen; Michael Argenziano; Alan Moskowitz; Deborah D Ascheim; Isaac George; Allan S Stewart; Mathew Williams; Annetine Gelijns; Yoshifumi Naka Journal: Ann Thorac Surg Date: 2009-04 Impact factor: 4.330
Authors: Hong Rae Kim; Sung-Ho Jung; Junho Yang; Min Su Kim; Tae-Jin Yun; Jae-Joong Kim; Jae Won Lee Journal: Korean J Thorac Cardiovasc Surg Date: 2020-12-05
Authors: Nadia Iannino; Amine Nasri; Agnès Räkel; Anique Ducharme; Kim Lachance; Normand Racine; Simon de Denus; Maxime Tremblay-Gravel; Annik Fortier; Michel White Journal: J Transplant Date: 2018-11-08
Authors: Daniel Oehler; Moritz Benjamin Immohr; Sophia Erbel-Khurtsidze; Hug Aubin; Raphael Romano Bruno; Hans Torulv Holst; Ralf Westenfeld; Patrick Horn; Malte Kelm; Igor Tudorache; Payam Akhyari; Artur Lichtenberg; Udo Boeken Journal: ESC Heart Fail Date: 2022-05-04
Authors: Daniel Oehler; Charlotte Böttger; Moritz Benjamin Immohr; Raphael Romano Bruno; Jafer Haschemi; Daniel Scheiber; Patrick Horn; Hug Aubin; Igor Tudorache; Ralf Westenfeld; Payam Akhyari; Malte Kelm; Artur Lichtenberg; Udo Boeken Journal: Life (Basel) Date: 2022-07-14